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Background. Tangier disease (TD) is a rare autosomal recessive disorder characterized by a 
deficiency or absence of high-density lipoprotein caused by mutations in the adenotriphosphate-
binding cassette transporter-1 gene (ABCA1). These lead to a defect in cellular cholesterol 
removal causing the deposition of cholesterol esters throughout reticuloendothelial system. 
Methods.  We enrolled a homozygous TD patient  and the heterozygous father. Whole plasmatic 
extracts were processed and mass spectrometry analyses of peptide fragments were performed on 
MALDI TOF/TOF equipment. Trypsin digestion produces a constant set of peptide fragments 
distinctive of each starting protein (finger print). Peptide ions are automatically processed by 
MASCOT and GPS Explorer software, which provide us the identification of starting proteins. 
Peaks, indicative of different peptides, also subjected to mass/mass analysis by means of 
fragmentation in a collision chamber. Such second mass analysis provided aminoacid sequence of 
peptide and the identification of possible post-translational modifications.  
Results. The very high sensitivity of the method allowed us to identify plasma proteins less 
peresented (<1.2 pg/ml). Apolipoprotein A-I, haptoglobin, alpha-2 macroglobulin, fibrinogen beta 
chain and isoform 1 of alpha-1 antitrypsin (C.I. 95%) resulted to be downregulated, while 
serotransferrin and Ig kappa resulted upregulated in the homozygous TD patient respect to the 
heterozygous. The same pattern was also observed by routine assays. 
Conclusions. The downregulation of the acute phase proteins observed in this case was 
unexpected. Proteome analyses may help in identification of abnormal metabolic pathways 
eventually activated in TD. 
